BSECompany Update20h ago · 28 Oct 2026, 01:47 pm
Newspaper publication of Unaudited Standalone and Consolidated Financial Results for the quarter & half year ended 30-09-2026
Indoco Remedies Ltd · 532612
✦ AI SummaryResults
Indoco Remedies Ltd has published unaudited standalone and consolidated financial results for the quarter and half year ended 30-09-2026, showing a net profit of Rs. 3,063 lakhs and a total income of Rs. 45,159 lakhs.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Indoco Remedies Ltd - 532612 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Attachments (1)
📄pdf
Download →
db42c813-fb90-4245-9e24-4f24e6571786.pdf
View document text
Date: 28th October, 2026
To To
The Listing Department The Listing Department
National Stock Exchange of India Limited Bombay Stock Exchange Limited
Exchange Plaza, Floor 25, P. J. Towers,
Bandra – Kurla Complex Dalal Street,
Bandra (East) Mumbai – 400 001
Mumbai – 400 051 Stock Code : 532612
Stock Code : INDOCO
Dear Sir/Madam,
Subject: Newspaper publication of Unaudited Standalone and Consolidated Financial
Results for the Quarter and Half Year Ended 30th September, 2026
Pursuant to the Regulation 30 and 47 of the SEBI (Listing Obligations and Disclosure
Requirements), Regulations, 2015, please find enclosed herewith copies of the newspaper
advertisement published today i.e. 28th October 2026 in Business Standard (All India Editions)
(English Newspaper) and Mumbai Lakshadeep (Marathi Newspaper) with respect to the
extract of Unaudited Standalone and Consolidated Financial Results of the Company for the
Quarter and Half Year Ended 30th September, 2026.
You are requested to kindly take the same on record.
Thanking you,
Yours faithfully,
For Indoco Remedies Limited
Ramanathan Hariharan
Company Secretary & Head- Legal
34 MUMBAI | WEDNESDAY, 28 OCTOBER 2026 Business Standard
@I\Im@ INDOCO REMEDIES LIMITED
Regd. Office: Indoco House, 166 CST Road, Kalina, Santacruz (East), Mumbai - 400098
Tel: +91-22-68791250 / 62871000 Email : compliance.officer@indoco.com Web : www.indoco.com CIN : L85190MH1947PLC005913
EXTRACTS OF STATEMENT OF STANDALOANNED CONSOLIDATED FINANCIALRESULTS FORTHE QUARTERAND HALF YEAR ENDED
30TH SEPTEMBER 2026 @ In Lakhs)
Standalone Consolidated
Quarter | Quarter | Quarter | Half Year | Half Year | Year Quarter | Quarter | Quarter | Half Year [ Half Year| Year
Sr. Particulars ended ended ended ended ended ended ended ended ended ended ended ended
No. 30.09.2026 | 30.06.2026 | 30.09.2025 | 30.09.2026 | 30.09.2025 (31.03.2026 | 30.09.2026 | 30.06.2026 | 30.09.2025 | 30.09.2026| 30.09.2025| 31.03.2026
(Unaudited) | (Unaudited) | (Unaudited) | (Unaudited)| (Unaudited)| (Audited) | (Unaudited)| (Unaudited)| (Unaudited){ (Unaudited) (Unaudited) (Audited)
1 | Total Income from Operations 45,159| 40,897 44,212 86,056 83,643|1,68,607| 52,017| 46,750| 48,467| 98,767 92,435|1,84,532
2 | Net Profit for the period
(before tax, exceptional and / or extraordinary items) (244) (412) 1,029 (656)[ (1,811) (861)| (1,295)| (1,962)| (1,300)| (3,256)| (4,965)| (10,357)
3 | Net Profit for the period before tax
(after exceptional and / or extraordinary items) 3,470 9,322 976| 12,792| (1,864) (1,147)] 2,419 7,772| (1,353)| 10,192| (5,018)| (10,651)
4 | Net Profit for the period after tax
(after exceptional and / or extraordinary items) 3,063| 8,232 1,505| 11,295 (1,301) (566)| 1,947 6,544 (921) 8,492 (4,555)| (9,870)
5 | Net Profit for the period after tax
(after exceptional and / or extraordinary items)
attributable to shareholders of the company 3,063 8,232 1,505| 11,295| (1,301) (566)[ 1,838 6,499 (793)| 8,338| (4,371)| (9,515)
6 | Total Comprehensive Income for the period
[Comprising Profit for the period (after tax)
and Other Comprehensive Income (after Tax)] 3,018| 8,187 1,562| 11,205| (1,203) (433) 1,913 6,612 (663)| 8,528| (4,312)| (8,608)
7 | Total Comprehensive Income for the period
[Comprising Profit for the period (after tax)
and Other Comprehensive Income (after Tax)]
attributable to shareholders of the company 3,018 8,187 1,662| 11,205 (1,203) (433)] 1,804 6,567 (535) 8,374 (4,128)| (8,253)
8 | Equity Share Capital 1,846 1,846 1,845 1,846| 1,845 1,846 1,846 1,846 1,845 1,846 1,845 1,846
9 | Reserves (excluding Revaluation Reserves) as shown
in the Audited Balance Sheet of the Previous year 1,08,073 92,082
10 | Earnings per share (of Rs. 2/- each) (for continuing
and discontinued operations) (not annualized)
(a) Basic 3.32 8.92 1.63 12.24| (1.41)| (0.61) 2.1 7.09| (1.00) 9.21 (4.94)| (10.70)
(b) Diluted 3.32 8.92 1.63 12.23| (1.41)| (0.61) 2.1 7.09| (1.00) 9.20| (4.94)| (10.69)
Notes :
1 The above is an extract of the detailed format of Quarterly Financial Results filed with the Stock exchange under Regulation 33 of the SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015. The full format of the Quarterly Financial Results are available on the Stock Exchange website i.e. www.bseindia.com and www.nseindia.com
and also the company's website:www.indoco.com
2 The above results were reviewed by the Audit Committee and approved and taken on record by the Board of Directors at the meeting held on 27th October, 2026.
By Order of the Board
For Indoco Remedies Ltd
Sd/-
Place : Mumbai E Aditi Panandikar
Date : October 27, 2026 Managing Director
guaR, f2. ¢ TR 03¢
i merdi€v)
(D nvece s=)p) Yol farfere=s
AicwuEieid i: Sg hTa, 268 WAg, HIfeHT, AR (L.), o5 - ¥00 0R¢.
T +3% IR €LBRIY0/ER¢L000 F-AA: 0 TS e: L85190MH1947PLC005913
f&. 30.0R.303% AN Wyl faudt a wemiaRarar wrft 7 welia
fa<ha frspufer srgaremar aRRT
(. arEid)
ot BT
a 30.03.20%% | 30.08.20%5 | 30.0030% | 30.08.0% | 30.0¢30% | o o o | 30.02.30%% | 30.05.20%% | 30.0330% | 30.08.0%% | 30080 | o oo
. TR Aol | A dverer | Ao Eueret | Ashdueret | R doeet AN AN ot | A dveret | AN Hueen | A0 @ueret | Ol Hoeret o
frromdt ot frromdt @ @ (Gramatfim) frmdt oot fomrdt @ TR S
(sroraTifem) | (srerarifem) | (seramdfim) | (seramdfm) | (srremdt) (srramadfem) | (srramfm) | (seemdfie) | (srremdie) | (srrarie)
2 | eT Sa= ¥4, 84% %0,£80 ¥¥,383 (8,048 C3,8¥3 | %,8¢,800 UR,0%0 8,640 ¥¢, %8s ¢, 8 ]3,¥34 | 3,04,
R | wremaffRedRe ar@ (e, SETeTS
/91 M STy ) (¥¥) (¥2R) 2,03% (848) (2,¢3%) (¢&?) (%,3%4) (%,383) (%,300) (3,3u8) (%,384) | (%0,34)
3 | Fgd FremaHifrsegRes aTr
(FTUETETCT H/AST STSET wH=d) 3,%0 2,3 Q8 33,L8% (2,¢8Y) (,2%09) 3,%8% 19,663 (2,343) 20,3%% (4,08¢) | (%0,84%)
¥ | e Hremaiseit aTrw
(FTUETETCHS 9 /AT STSET wH=d) 3,083 AR 2,404 28,384 (2,302) (4&8) 2,%%9 €,U¥Y (]3%) ¢,¥R (¥,u44) (R,¢90)
& | e HremaifwreRre aTr
(ST | STETHS refuvETd) HoreET
WTTHTRTS Hefr 3,083 AR 2,404 22,34 (2,30%) (4&8) 2,43¢ §,%%% (983) ¢,33¢ (¥,30%) (],434)
& | FreraHfieRar TR wdEEeR I
(T HRAT (HTITETT) THTT 3T
FEGATIR (RTITATE TT) 3,08¢ [A320 2,483 28,304 (8,03) (¥33) 2,383 £,62 (883) AR (%,38R) (¢,80¢)
© fiohiiaT TRV FEEHTRIh I~
(FreTaHfisplar (FHTTET) THT 3T
FAGHTAIYR (HTTETT) FeT FHEA
HHIAT WATHEhTR Fefia 3,0%¢ ¢,8¢00 2,U8R 28,304 (%,303) (¥33) 2,80% €480 (434) ¢,39% (¥,23¢) (¢,343)
¢ | Emm wigad 2,¢%8 9,0%5 2,0%4% 9,L%8 2,84 9,0%8 2,¢%8 9,0%% 9,0%4% 9,L%8 9,0%Y% 2,0%%
R | Tt (Te STesar)
T TNt @i dree
2,0¢,003 83,0
%0 |3 WRiRIER (J%, 3/-) (3r@fed@
Gfea TRATeHTRRaT) (i)
3) g LR ¢ .83 23.3% (2.%2) (0.8%) R.2% .08 (2.00) R.R% (%.]%) (%0.90)
) Hefiga 3.3 ¢.83 2.83 23.33 (2.¥2) (0.83) R.2% .08 (%.00) ].30 (¥.%) (R0.€%)
dar:
2. e quef&i1 cdett (gfuegar sttvarar 9 fame stavamas o, 02y = fafe 33 siaia =i wrRSERS racRaT sere famrd foxfta frepute sreareren frega ST ARt o, fomE
fercrar freehi=an oteaTei S0l TTET Wik TR SEs Jedrse rfd El TG hO JeETEe T T IR,
R. 9l frepufe sramde afidigR g HoaTd 31 B ST HeTesh HSBigR A 8. 26.20.303% TS IR Tseiedn THA T Hofl QUATT 3% el Teiguit HIvaTd 3TTefl 3.
TeeTe
Zewrige fonr. wtRar
fortieh@ R9.20.%0%% IR HelTeTh